APP and Alzheimer disease: It remains uncertain whether and how BACE1 is associated with aging or neurodegenerative disease since under our experimental conditions BACE1 mRNA levels significantly decreased during physiological aging and beside the increase in the expression of APP, they remain unchanged in AD-PBMCs.